MNTA’s cash flow occurs only if a competing generic Lovenox is commercially launched.
If TEVA's generic Lovenox is approved by the FDA, how likely is it that they could launch prior to a ruling by the court regarding the patent infringement?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.